FDA clears Outset Medical’s TabloCart with prefiltration for enhanced dialysis treatment
Outset Medical, Inc., a leader in innovative medical technology, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ... Read More
Outset Medical raises $125m funding for Tablo Hemodialysis System
US-based medical technology company Outset Medical has secured $125 million funding in a Series E financing round for the commercialization of Tablo Hemodialysis System, an ... Read More